You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 8, August 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Dermatology
 •Melanoma
 •Alert me on articles by topic

Neoadjuvant Interferon alfa-2b Treatment in a Murine Model for Metastatic Ocular Melanoma

A Preliminary Study

Stefan Dithmar, MD; Dario Rusciano, PhD; Michael J. Lynn, MS; David H. Lawson, MD; Cheryl A. Armstrong, MD; Hans E. Grossniklaus, MD

Arch Ophthalmol. 2000;118:1085-1089.

Objectives  To investigate the treatment of metastasis from uveal melanoma and to test the effect of interferon (IFN) alfa-2b in a murine model.

Methods  The B16-LS9 tissue culture melanoma cells were inoculated into the posterior intraocular compartment of 3 groups of C57BL/6 mice. The inoculated eyes were enucleated at 9 days and the mice were euthanized at 26 days after inoculation; the site and number of metastases were determined using standard histologic techniques. Group 1 was the control group; group 2 was given 20,000 international units (IU) of IFN alfa-2b intramuscularly 12 hours before enucleation, and group 3 received daily injections of 20,000 IU of IFN alfa-2b intramuscularly starting 4 days before enucleation.

Results  Pulmonary metastases were detected in 57%, 33%, and 0% of groups 1, 2, and 3, respectively; hepatic micrometastases were detected only in group 1. These results showed a significant decrease in hepatic metastases in mice receiving IFN alfa-2b vs controls (P = .005).

Conclusion  Treatment with IFN alfa-2b results in decreased hepatic metastases from intraocular melanoma in a murine model.


From the Departments of Ophthalmology (Drs Grossniklaus and Rusciano), Medicine (Dr Lawson), and Dermatology (Dr Armstrong), and the School of Public Health (Mr Lynn), Emory University School of Medicine, Atlanta, Ga; and the Friedrich Miescher Institut, Basel, Switzerland (Dr Rusciano).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differential Expression of Chemokine Receptors on Uveal Melanoma Cells and Their Metastases
Li et al.
IOVS 2008;49:636-643.
ABSTRACT | FULL TEXT  

The relation between c-myc expression and interferon sensitivity in uveal melanoma
Tulley et al.
Br. J. Ophthalmol. 2004;88:1563-1567.
ABSTRACT | FULL TEXT  

Interferon {alpha}2b Decreases Hepatic Micrometastasis in a Murine Model of Ocular Melanoma by Activation of Intrinsic Hepatic Natural Killer Cells
Yang et al.
IOVS 2004;45:2056-2064.
ABSTRACT | FULL TEXT  

Reduction of Liver Metastasis of Intraocular Melanoma by Interferon-{beta} Gene Transfer
Alizadeh et al.
IOVS 2003;44:3042-3051.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.